Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 basket trial of sotorasib + panitumumab in KRAS G12C-mutated advanced solid tumors (KRAUS)
KCT0008706Phase 2Not yet recruiting
- Sponsor
- Amgen
- Start
- Sep 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sotorasib and panitumumab in Nonhematologic neoplasms, sponsored by Amgen. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
sotorasibpanitumumab
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on KCT0008706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008706.